Arterial Occlusive Diseases  >>  inclacumab (PF-07940370)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
inclacumab (PF-07940370) / Roche, Pfizer, Genmab
NCT01245634: A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery

Completed
2
384
US, Canada
Placebo, RO4905417
Hoffmann-La Roche
Coronary Heart Disease, Graft Occlusion, Vascular
05/13
05/13

Download Options